Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries
HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endot...
Gespeichert in:
Veröffentlicht in: | Journal of acquired immune deficiency syndromes (1999) 2005-09, Vol.40 (1), p.12-19 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 19 |
---|---|
container_issue | 1 |
container_start_page | 12 |
container_title | Journal of acquired immune deficiency syndromes (1999) |
container_volume | 40 |
creator | Chai, Hong Yang, Hui Yan, Shaoyu Li, Min Lin, Peter H Lumsden, Alan B Yao, Qizhi Chen, Changyi |
description | HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications. |
doi_str_mv | 10.1097/01.qai.0000172368.05327.7b |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21047565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>901464671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</originalsourceid><addsrcrecordid>eNpdkduO0zAQhiMEYg_wCshaCe5SfHbCXVXtodJKIAF7aznJWPWS2l07UeHtmdJKlfCNPeNvZn77r6obRheMtuYzZYsXFxYUFzNc6GZBleBmYbpX1SVrpaxN08jXeFZc1ZIJdVFdlfKMuJayfVtdMM2wzqjLan_rPfRTIckTRR7WT-RbThO4AmQdN6ELU8p4GcmTK2mbMCJ3c-yngCkXB_J93kFOv8MAZBkPSSwf5uN9wCjlPkQgq5RTdPkPWeYJcoDyrnrj3Vjg_Wm_rn7e3f5YPdSPX-_Xq-Vj3SvKeS0a0O1AufLOQe_bofMSnAbFqGQIMOV9Z1SrvFCNASGM8o3WjaRsYI3uxHX16dh3l9PLDGWy21B6GEcXIc3FcmxklFYI3vwHPqc5R9RmuRCaN1oIhL4coT6nUjJ4u8thi--yjNqDN5Yyi97Yszf2nzfWHKR8OE2Yuy0M59KTGQh8PAGu9G702cU-lDNnmDBUaeTkkdunEX-z_BrnPWS7ATdOGxzNOGqVNadU0ZYyWh_UcPEXbL6ntg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233628633</pqid></control><display><type>article</type><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><source>Freely Accessible Journals</source><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><creator>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</creator><creatorcontrib>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</creatorcontrib><description>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/01.qai.0000172368.05327.7b</identifier><identifier>PMID: 16123675</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins, Inc</publisher><subject>Animals ; Antioxidants ; Biological and medical sciences ; Bradykinin - pharmacology ; Carbamates ; Coronary vessels ; Coronary Vessels - drug effects ; Coronary Vessels - metabolism ; Coronary Vessels - physiopathology ; Down-Regulation - drug effects ; Fundamental and applied biological sciences. Psychology ; HIV ; HIV Protease Inhibitors - adverse effects ; HIV Protease Inhibitors - pharmacology ; Human immunodeficiency virus ; Human viral diseases ; Indinavir - pharmacology ; Infectious diseases ; Medical sciences ; Methionine - analogs & derivatives ; Methionine - drug effects ; Microbiology ; Miscellaneous ; Muscle Contraction - drug effects ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - physiopathology ; Myography ; Nelfinavir - pharmacology ; Nitric oxide ; Nitric Oxide Synthase - genetics ; Nitric Oxide Synthase - metabolism ; Organ Culture Techniques ; Protease inhibitors ; Ritonavir - pharmacology ; RNA, Messenger - analysis ; Saquinavir - pharmacology ; Selenium Compounds - pharmacology ; Side effects ; Sulfonamides - pharmacology ; Superoxides - metabolism ; Swine ; Vasomotor System - drug effects ; Vasomotor System - physiopathology ; Viral diseases ; Virology</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2005-09, Vol.40 (1), p.12-19</ispartof><rights>2005 Lippincott Williams & Wilkins, Inc.</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Lippincott Williams & Wilkins Sep 1, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</citedby><cites>FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-200509010-00002$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00126334-200509010-00002$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>315,781,785,4610,27926,27927,64668,65463</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17137056$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16123675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chai, Hong</creatorcontrib><creatorcontrib>Yang, Hui</creatorcontrib><creatorcontrib>Yan, Shaoyu</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Lin, Peter H</creatorcontrib><creatorcontrib>Lumsden, Alan B</creatorcontrib><creatorcontrib>Yao, Qizhi</creatorcontrib><creatorcontrib>Chen, Changyi</creatorcontrib><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Biological and medical sciences</subject><subject>Bradykinin - pharmacology</subject><subject>Carbamates</subject><subject>Coronary vessels</subject><subject>Coronary Vessels - drug effects</subject><subject>Coronary Vessels - metabolism</subject><subject>Coronary Vessels - physiopathology</subject><subject>Down-Regulation - drug effects</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV</subject><subject>HIV Protease Inhibitors - adverse effects</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Indinavir - pharmacology</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Methionine - analogs & derivatives</subject><subject>Methionine - drug effects</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - physiopathology</subject><subject>Myography</subject><subject>Nelfinavir - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase - genetics</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Organ Culture Techniques</subject><subject>Protease inhibitors</subject><subject>Ritonavir - pharmacology</subject><subject>RNA, Messenger - analysis</subject><subject>Saquinavir - pharmacology</subject><subject>Selenium Compounds - pharmacology</subject><subject>Side effects</subject><subject>Sulfonamides - pharmacology</subject><subject>Superoxides - metabolism</subject><subject>Swine</subject><subject>Vasomotor System - drug effects</subject><subject>Vasomotor System - physiopathology</subject><subject>Viral diseases</subject><subject>Virology</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkduO0zAQhiMEYg_wCshaCe5SfHbCXVXtodJKIAF7aznJWPWS2l07UeHtmdJKlfCNPeNvZn77r6obRheMtuYzZYsXFxYUFzNc6GZBleBmYbpX1SVrpaxN08jXeFZc1ZIJdVFdlfKMuJayfVtdMM2wzqjLan_rPfRTIckTRR7WT-RbThO4AmQdN6ELU8p4GcmTK2mbMCJ3c-yngCkXB_J93kFOv8MAZBkPSSwf5uN9wCjlPkQgq5RTdPkPWeYJcoDyrnrj3Vjg_Wm_rn7e3f5YPdSPX-_Xq-Vj3SvKeS0a0O1AufLOQe_bofMSnAbFqGQIMOV9Z1SrvFCNASGM8o3WjaRsYI3uxHX16dh3l9PLDGWy21B6GEcXIc3FcmxklFYI3vwHPqc5R9RmuRCaN1oIhL4coT6nUjJ4u8thi--yjNqDN5Yyi97Yszf2nzfWHKR8OE2Yuy0M59KTGQh8PAGu9G702cU-lDNnmDBUaeTkkdunEX-z_BrnPWS7ATdOGxzNOGqVNadU0ZYyWh_UcPEXbL6ntg</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Chai, Hong</creator><creator>Yang, Hui</creator><creator>Yan, Shaoyu</creator><creator>Li, Min</creator><creator>Lin, Peter H</creator><creator>Lumsden, Alan B</creator><creator>Yao, Qizhi</creator><creator>Chen, Changyi</creator><general>Lippincott Williams & Wilkins, Inc</general><general>Lippincott Williams & Wilkins</general><general>Lippincott Williams & Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20050901</creationdate><title>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</title><author>Chai, Hong ; Yang, Hui ; Yan, Shaoyu ; Li, Min ; Lin, Peter H ; Lumsden, Alan B ; Yao, Qizhi ; Chen, Changyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5022-38e69d025faaecf9dbf4ea6e5104102215ffb7595f3587e3375f8668401d186b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Biological and medical sciences</topic><topic>Bradykinin - pharmacology</topic><topic>Carbamates</topic><topic>Coronary vessels</topic><topic>Coronary Vessels - drug effects</topic><topic>Coronary Vessels - metabolism</topic><topic>Coronary Vessels - physiopathology</topic><topic>Down-Regulation - drug effects</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV</topic><topic>HIV Protease Inhibitors - adverse effects</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Indinavir - pharmacology</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Methionine - analogs & derivatives</topic><topic>Methionine - drug effects</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - physiopathology</topic><topic>Myography</topic><topic>Nelfinavir - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase - genetics</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Organ Culture Techniques</topic><topic>Protease inhibitors</topic><topic>Ritonavir - pharmacology</topic><topic>RNA, Messenger - analysis</topic><topic>Saquinavir - pharmacology</topic><topic>Selenium Compounds - pharmacology</topic><topic>Side effects</topic><topic>Sulfonamides - pharmacology</topic><topic>Superoxides - metabolism</topic><topic>Swine</topic><topic>Vasomotor System - drug effects</topic><topic>Vasomotor System - physiopathology</topic><topic>Viral diseases</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chai, Hong</creatorcontrib><creatorcontrib>Yang, Hui</creatorcontrib><creatorcontrib>Yan, Shaoyu</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Lin, Peter H</creatorcontrib><creatorcontrib>Lumsden, Alan B</creatorcontrib><creatorcontrib>Yao, Qizhi</creatorcontrib><creatorcontrib>Chen, Changyi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chai, Hong</au><au>Yang, Hui</au><au>Yan, Shaoyu</au><au>Li, Min</au><au>Lin, Peter H</au><au>Lumsden, Alan B</au><au>Yao, Qizhi</au><au>Chen, Changyi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>40</volume><issue>1</issue><spage>12</spage><epage>19</epage><pages>12-19</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2 production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>16123675</pmid><doi>10.1097/01.qai.0000172368.05327.7b</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-4135 |
ispartof | Journal of acquired immune deficiency syndromes (1999), 2005-09, Vol.40 (1), p.12-19 |
issn | 1525-4135 1944-7884 |
language | eng |
recordid | cdi_proquest_miscellaneous_21047565 |
source | Freely Accessible Journals; MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete |
subjects | Animals Antioxidants Biological and medical sciences Bradykinin - pharmacology Carbamates Coronary vessels Coronary Vessels - drug effects Coronary Vessels - metabolism Coronary Vessels - physiopathology Down-Regulation - drug effects Fundamental and applied biological sciences. Psychology HIV HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - pharmacology Human immunodeficiency virus Human viral diseases Indinavir - pharmacology Infectious diseases Medical sciences Methionine - analogs & derivatives Methionine - drug effects Microbiology Miscellaneous Muscle Contraction - drug effects Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - physiopathology Myography Nelfinavir - pharmacology Nitric oxide Nitric Oxide Synthase - genetics Nitric Oxide Synthase - metabolism Organ Culture Techniques Protease inhibitors Ritonavir - pharmacology RNA, Messenger - analysis Saquinavir - pharmacology Selenium Compounds - pharmacology Side effects Sulfonamides - pharmacology Superoxides - metabolism Swine Vasomotor System - drug effects Vasomotor System - physiopathology Viral diseases Virology |
title | Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary Arteries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%205%20HIV%20Protease%20Inhibitors%20on%20Vasomotor%20Function%20and%20Superoxide%20Anion%20Production%20in%20Porcine%20Coronary%20Arteries&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Chai,%20Hong&rft.date=2005-09-01&rft.volume=40&rft.issue=1&rft.spage=12&rft.epage=19&rft.pages=12-19&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/10.1097/01.qai.0000172368.05327.7b&rft_dat=%3Cproquest_cross%3E901464671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233628633&rft_id=info:pmid/16123675&rfr_iscdi=true |